Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers
Maysa Abu‐Khalaf, K. Alex Hodge, Christos Hatzis, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
Iseult Browne, Fabrice André, Sarat Chandarlapaty, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 4, pp. e139-e151
Closed Access | Times Cited: 33
Adverse Cardiovascular Events Associated With Cyclin‐Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
Michael G. Fradley, Nam Nguyen, David Madnick, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 24
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes
Abhibhav Sharma, Julia Debik, Bjørn Naume, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence
Claudio Vernieri, Francesca Ligorio, Debu Tripathy, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1644-1667
Closed Access | Times Cited: 8
Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
Lin Dong, Chao Liu, Haoyang Sun, et al.
Cancer Letters (2024) Vol. 593, pp. 216956-216956
Closed Access | Times Cited: 4
PARP12-mediated ADP-ribosylation contributes to breast cancer cell fate by regulating AKT activation and DNA-damage response
Anupama Pavithran, Maria Matarese, Barbara Morone, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Application of the Human Proteome in Disease, Diagnosis, and Translation into Precision Medicine: Current Status and Future Prospects
Yawen Xie, Xiaoying Chen, Min Xu, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 681-681
Open Access
Multi-omic profiling in breast cancer: utility for advancing diagnostics and clinical care
Emna El Gazzah, Scott Parker, Mariaelena Pierobon
Expert Review of Molecular Diagnostics (2025)
Closed Access
Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boards
Allison L. Hunt, Jamie Randall, Mahesh Mansukhani, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C. Wescott, Xiaopeng Sun, Paula I. González-Ericsson, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 1120-1134
Open Access | Times Cited: 2
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
Chunfang Hao, Yiran Wei, Wenjing Meng, et al.
Cancer Treatment Reviews (2024), pp. 102861-102861
Open Access | Times Cited: 2
Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6
Florencia Cascardo, Micaela Vivanco, María Cecilia Perrone, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways
Gizem Yayli, Alexa Tokofsky, Utthara Nayar
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Risk of Cardiovascular Events with Cyclin-Dependent Kinases 4 and 6 (CDK 4/6) Inhibitors among Patients with Advanced Breast Cancer: A Systematic Review and Network Meta-Analysis
Yi‐Shao Liu, Kevin Dong, Chanhyun Park
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 11
Open Access | Times Cited: 2
Acquired resistance to CDK4/6 inhibition is associated with dysregulation of multiple pathways including cyclin D-CDK4/6-RB, EGFR/HER, AKT/mTOR and IFN signaling
Melanie Spears, Lauren Bathurst, Linda M. Liao, et al.
Research Square (Research Square) (2024)
Open Access
Analysis of PIK3CA mutations in the primary and recurrent tumors of hormone receptor positive/human epidermal growth factor receptor 2 negative breast cancer
Yue Wang, Xin Li, Shuang Zhang, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 9, pp. 1024-1031
Closed Access
Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial
Eriko Tokunaga, Hiroji Iwata, Mitsuya Itoh, et al.
Breast Cancer (2024)
Open Access
Integrating Functional Protein Drug Target Data into a Precision Oncology Molecular Tumor Board
Allison L. Hunt, Jamie Randall, Mahesh Mansukhani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Protein biomarkers for subtyping breast cancer and implications for future research: a 2024 update
Claudius Mueller, Justin B. Davis, Virginia Espina
Expert Review of Proteomics (2024) Vol. 21, Iss. 9-10, pp. 401-416
Closed Access
Atrial Fibrillation and Cancer—Epidemiology, Mechanisms, and Management
Nathaniel E. Davis, Narut Prasitlumkum, Nicholas Y. Tan
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7753-7753
Open Access
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology
Mariaelena Pierobon, Emanuel F. Petricoin
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 12, pp. 1057-1059
Open Access | Times Cited: 1
Targeting Stat3 Potentiates Cdk4/6 Inhibitors Therapy in Hnscc
Dong Lin, Haoyang Sun, Chao Liu, et al.
(2024)
Closed Access
The Sonic hedgehog pathway inhibitor GDC0449 induces autophagic death in human Medulloblastoma Daoy cells
Qi Zhang, Wanjing Zou, Longtao He, et al.
Ultrastructural Pathology (2023) Vol. 47, Iss. 6, pp. 529-539
Closed Access
Page 1

Scroll to top